
Keywords: CVT; cerebral venous thrombosis; PAI-1; plasminogen activator inhibitor â 1; PC; protein C; PS; protein S; AT; antithrombin III; FVL; Factor V Leiden; tPA; tissue plasminogen activator; PLG; plasminogen; A2-AP; alpha-2-antiplasmin; APLA; antiphospholip